Clinical Trial Update: PPALM-Palm Oil and Pentoxifylline Against Late Morbidity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PPALM-Palm Oil and Pentoxifylline for late morbidity after pelvic radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long-term Adverse Effects of Radiotherapy For Pelvic Cancer

Drugs mentioned

• PPALM-Palm Oil
• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Long-term Adverse Effects of Radiotherapy for Pelvic Cancer | Phase 2 | Status: COMPLETED